SciCombinator

Discover the most talked about and latest scientific content & concepts.

Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 1 Dec 2017

S Winterhalter, A Eckert, GA Vom Brocke, A Schneider, D Pohlmann, D Pilger, AM Joussen, M Rehak and U Grittner
Abstract
To evaluate the therapeutic outcome for dexamethasone implant (DEX) or intravitreal ranibizumab (IVR) injections over 6 months in patients with macular edema due to branch or central retinal vein occlusion (BRVO, CRVO), in a real-life setting.
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
Macular degeneration, Central retinal vein occlusion, Clinical trial, Central retinal vein, Dexamethasone
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com